France - Business Enterprise Expenditure on R&D Performed in the Pharmaceutical Industry
Since 2014, France Business Enterprise Expenditure on R&D Performed in the Pharmaceutical Industry grew 0.4% year on year. In 2019, the country was number 10 among other countries in Business Enterprise Expenditure on R&D Performed in the Pharmaceutical Industry at $1,080,008,891 Million PPP. France is overtaken by Spain, which was number 9 at $1,127,374,718.22 Million PPP and is followed by Italy at $894,380,465.38 Million PPP. United States lead the ranking with $70,565,318,932.39 Million PPP in 2019, that is an increase of 3.3% compared to 2018. China, Japan and Germany respectively ranked number 2, 3 and 4 in this ranking. Iceland recorded the best 5 years average growth at +43.9% per year, while Lithuania was the worst growing country at -42.6% per year.
Loading...
| Date | Million US Dollars PPP |
|---|---|
| 2019 | 1,080,008,891.00 |
| 2018 | 1,081,562,122.75 |
| 2017 | 1,083,875,474.76 |
| 2016 | 1,087,637,052.83 |
| 2015 | 1,100,224,756.02 |
How does France rank in Business Enterprise Expenditure on R&D Performed in the Pharmaceutical Industry?
| # | 69 Countries | Million US Dollars PPP | Last | YoY | 5‑years CAGR | ||
|---|---|---|---|---|---|---|---|
| 1 |
#1
United States
|
70,565,318,932.39 | 2019 | +3.3 % | +4.5 % | View data | |
| 2 |
#2
China
|
13,956,388,273.35 | 2019 | +4.5 % | +6.1 % | View data | |
| 9 |
#9
Spain
|
1,127,374,718.22 | 2019 | +2.6 % | +5.3 % | View data | |
| 10 |
#10
France
|
1,080,008,891.00 | 2019 | -0.1 % | +0.4 % | View data | |
| 11 |
#11
Italy
|
894,380,465.38 | 2019 | +2.0 % | +5.3 % | View data | |